MAPK9 and Alzheimer disease: Similarly, Aβ-induced tau hyperphosphorylation involves several MAPKs (ERK1/2, SAPK/JNK, and p38), all of which utilize tyrosine phosphorylation, leading to neurofibrillary degeneration in AD [30].